Patrick Lamy, Senior VP, Commercial Strategy: Akero Therapeutics AKRO Sell · Filed 25/06/20

Trade details

Type: Insider sale
Amount: $27,545
Shares · price: 500 sh · $55.09 a share
Held after: 32,573 sh
Stock: Akero Therapeutics AKRO
Person: Patrick LamySenior VP, Commercial Strategy
Trade date: 25/06/16
Filed: 25/06/20
Days to filing: 4 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/17~25/07/16

Patrick Lamy's recent trades

Patrick LamySenior VP, Commercial Strategy
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$105.8K
2,000 sh
$105.8K
Filed 25/07/03
Traded 25/07/01
Patrick LamySenior VP, Commercial Strategy
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$47.8K
875 sh
$47.8K
Filed 25/06/20
Traded 25/06/20
Patrick LamySenior VP, Commercial Strategy
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$80.7K
1,500 sh
$80.7K
Filed 25/06/20
Traded 25/06/16
Patrick LamySenior VP, Commercial Strategy
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$49.6K
919 sh
$49.6K
Filed 25/06/12
Traded 25/06/10
Patrick LamySenior VP, Commercial Strategy
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$166.5K
3,300 sh
$166.5K
Filed 25/06/04
Traded 25/06/02